{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T20:31:58Z","timestamp":1782246718827,"version":"3.54.5"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.humpath.2020.10.001","type":"journal-article","created":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T11:44:46Z","timestamp":1602503086000},"page":"50-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Data set for reporting of carcinoma of the adrenal cortex: explanations and recommendations of the guidelines from the International Collaboration on Cancer Reporting"],"prefix":"10.1016","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0641-8873","authenticated-orcid":false,"given":"Thomas J.","family":"Giordano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Berney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6871-1296","authenticated-orcid":false,"given":"Ronald R.","family":"de Krijger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3666-2546","authenticated-orcid":false,"given":"Lori","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6170-6398","authenticated-orcid":false,"given":"Martin","family":"Fassnacht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozgur","family":"Mete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Papathomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Papotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironobu","family":"Sasano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3714-1432","authenticated-orcid":false,"given":"Lester D.R.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Volante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9447-1967","authenticated-orcid":false,"given":"Anthony J.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2020.10.001_bib1","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1210\/jc.2005-2639","article-title":"Clinical review: adrenocortical carcinoma: clinical update","volume":"91","author":"Allolio","year":"2006","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.humpath.2020.10.001_bib2","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1016\/j.ejca.2013.02.034","article-title":"Adrenocortical carcinoma: a population-based study on ncidence and survival in The Netherlands since 1993","volume":"49","author":"Kerkhofs","year":"2013","journal-title":"Eur J Canc"},{"key":"10.1016\/j.humpath.2020.10.001_bib3","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1210\/er.2013-1029","article-title":"Adrenocortical carcinoma","volume":"35","author":"Else","year":"2014","journal-title":"Endocr Rev"},{"key":"10.1016\/j.humpath.2020.10.001_bib4","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1210\/jc.2010-0990","article-title":"Approach to the patient with adrenocortical carcinoma","volume":"95","author":"Lacroix","year":"2010","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.humpath.2020.10.001_bib5","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-18-0608","article-title":"European society of endocrinology clinical practice guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the study of adrenal tumors","volume":"179","author":"Fassnacht","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.humpath.2020.10.001_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2020.08.2099","article-title":"Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up(\u2020)","author":"Fassnacht","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2020.10.001_bib7","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1210\/jc.2016-2894","article-title":"Long-term outcomes of adjuvant mitotane therapy in patients with radically resected adrenocortical carcinoma","volume":"102","author":"Berruti","year":"2017","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.humpath.2020.10.001_bib8","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1093\/annonc\/mdv329","article-title":"Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study","volume":"26","author":"Lib\u00e9","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2020.10.001_bib9","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1210\/jc.2013-3020","article-title":"Update in adrenocortical carcinoma","volume":"98","author":"Fassnacht","year":"2013","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.humpath.2020.10.001_bib10","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-2288-9-34","article-title":"Extending an evidence hierarchy to include topics other than treatment: revising the Australian 'levels of evidence","volume":"9","author":"Merlin","year":"2009","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.humpath.2020.10.001_bib11","series-title":"WHO classification of tumours of endocrine organs","article-title":"Adrenal cortical carcinoma","author":"Giordano","year":"2017"},{"key":"10.1016\/j.humpath.2020.10.001_bib12","series-title":"WHO classification of tumours of endocrine organs","author":"Lloyd","year":"2017"},{"key":"10.1016\/j.humpath.2020.10.001_bib13","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.humpath.2009.03.010","article-title":"The Weiss system for evaluating adrenocortical neoplasms: 25 years later","volume":"40","author":"Lau","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2020.10.001_bib14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/106689690401200304","article-title":"Adrenocortical oncocytic tumors: report of 10 cases and review of the literature","volume":"12","author":"Bisceglia","year":"2004","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.humpath.2020.10.001_bib15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00000478-198403000-00001","article-title":"Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors","volume":"8","author":"Weiss","year":"1984","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2020.10.001_bib16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/PAS.0000000000000943","article-title":"Diagnostic and prognostic biomarkers of adrenal cortical carcinoma","volume":"42","author":"Mete","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2020.10.001_bib17","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/ng.2953","article-title":"Integrated genomic characterization of adrenocortical carcinoma","volume":"46","author":"Assie","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2020.10.001_bib18","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ccell.2016.04.002","article-title":"Comprehensive pan-genomic characterization of adrenocortical carcinoma","volume":"29","author":"Zheng","year":"2016","journal-title":"Canc Cell"},{"key":"10.1016\/j.humpath.2020.10.001_bib19","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00000478-198903000-00004","article-title":"Pathologic features of prognostic significance in adrenocortical carcinoma","volume":"13","author":"Weiss","year":"1989","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2020.10.001_bib20","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.anndiagpath.2013.05.005","article-title":"Are we counting mitoses correctly?","volume":"17","author":"Yigit","year":"2013","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.humpath.2020.10.001_bib21","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1158\/1078-0432.CCR-08-1067","article-title":"Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling","volume":"15","author":"Giordano","year":"2009","journal-title":"Clin Canc Res"},{"key":"10.1016\/j.humpath.2020.10.001_bib22","first-page":"199","article-title":"Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluations in human malignancies","volume":"1","author":"Gerdes","year":"1990","journal-title":"Semin Canc Biol"},{"key":"10.1016\/j.humpath.2020.10.001_bib23","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1210\/jc.2014-3182","article-title":"Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection","volume":"100","author":"Beuschlein","year":"2015","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.humpath.2020.10.001_bib24","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/modpathol.2013.230","article-title":"Comparative diagnostic and prognostic performances of the hematoxylin-eosin and phospho-histone H3 mitotic count and Ki-67 index in adrenocortical carcinoma","volume":"27","author":"Duregon","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2020.10.001_bib25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1507\/endocrj.K07-079","article-title":"Immunohistochemistry of a proliferation marker Ki67\/MIB1 in adrenocortical carcinomas: Ki67\/MIB1 labeling index is a predictor for recurrence of adrenocortical carcinomas","volume":"55","author":"Morimoto","year":"2008","journal-title":"Endocr J"},{"key":"10.1016\/j.humpath.2020.10.001_bib26","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1038\/s41379-018-0077-8","article-title":"Clinicopathological description of 43 oncocytic adrenocortical tumors: importance of Ki-67 in histoprognostic evaluation","volume":"31","author":"Renaudin","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2020.10.001_bib27","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s13000-014-0216-6","article-title":"Automated Selection of Hotspots (ASH): enhanced automated segmentation and adaptive step finding for Ki67 hotspot detection in adrenal cortical cancer","volume":"9","author":"Lu","year":"2014","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.humpath.2020.10.001_bib28","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.humpath.2015.10.017","article-title":"Comparison of the methods for measuring the Ki-67 labeling index in adrenocortical carcinoma: manual versus digital image analysis","volume":"53","author":"Yamazaki","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2020.10.001_bib29","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/PAS.0000000000000574","article-title":"An international Ki67 reproducibility study in adrenal cortical carcinoma","volume":"40","author":"Papathomas","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2020.10.001_bib30","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.surg.2018.04.068","article-title":"Longitudinal patterns of recurrence in patients with adrenocortical carcinoma","volume":"165","author":"Glenn","year":"2019","journal-title":"Surgery"},{"key":"10.1016\/j.humpath.2020.10.001_bib31","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ijrobp.2015.01.007","article-title":"Adjuvant radiation therapy improves local control after surgical resection in patients with localized adrenocortical carcinoma","volume":"92","author":"Sabolch","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.humpath.2020.10.001_bib32","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1200\/JCO.2012.48.0988","article-title":"Adrenocortical carcinoma is a lynch syndrome-associated cancer","volume":"31","author":"Raymond","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2020.10.001_bib33","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/cncr.24030","article-title":"Limited prognostic value of the 2004 International Union against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification","volume":"115","author":"Fassnacht","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2020.10.001_bib34","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/PAS.0b013e31828d387b","article-title":"The reticulin algorithm for adrenocortical tumor diagnosis: a multicentric validation study on 245 unpublished cases","volume":"37","author":"Duregon","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2020.10.001_bib35","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2559.2009.03423.x","article-title":"Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification","volume":"55","author":"Volante","year":"2009","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2020.10.001_bib36","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/1097-0142(19850215)55:4<766::AID-CNCR2820550414>3.0.CO;2-7","article-title":"Morphologic characteristics of benign and malignant adrenocortical tumors","volume":"55","author":"van Slooten","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2020.10.001_bib37","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-2559.2007.02747.x","article-title":"The prognostic value of two different histopathological scoring systems for adrenocortical carcinomas","volume":"51","author":"van't Sant","year":"2007","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2020.10.001_bib38","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1097\/00000478-200212000-00009","article-title":"Weiss system revisited: a clinicopathologic and immunohistochemical study of 49 adrenocortical tumors","volume":"26","author":"Aubert","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2020.10.001_bib39","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/01.pcr.0000175102.22075.54","article-title":"Oncocytic adrenocortical tumors","volume":"10","author":"Bisceglia","year":"2005","journal-title":"Pathol Case Rev"},{"key":"10.1016\/j.humpath.2020.10.001_bib40","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.humpath.2014.11.015","article-title":"Helsinki score-a novel model for prediction of metastases in adrenocortical carcinomas","volume":"46","author":"Pennanen","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2020.10.001_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2016.09.035","article-title":"Validation of the prognostic role of the \"Helsinki Score\" in 225 cases of adrenocortical carcinoma","volume":"62","author":"Duregon","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2020.10.001_bib42","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/00000478-200307000-00001","article-title":"Adrenal cortical neoplasms in the pediatric population: a clinicopathologic and immunophenotypic analysis of 83 patients","volume":"27","author":"Wieneke","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2020.10.001_bib43","doi-asserted-by":"crossref","first-page":"6302","DOI":"10.1038\/ncomms7302","article-title":"Genomic landscape of paediatric adrenocortical tumours","volume":"6","author":"Pinto","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.humpath.2020.10.001_bib44","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/s41379-018-0174-8","article-title":"Revisiting the role of the pathological grading in pediatric adrenal cortical tumors: results from a national cohort study with pathological review","volume":"32","author":"Picard","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2020.10.001_bib45","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1677\/ERC-08-0237","article-title":"Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas","volume":"16","author":"Soon","year":"2009","journal-title":"Endocr Relat Canc"},{"key":"10.1016\/j.humpath.2020.10.001_bib46","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1530\/ERC-16-0266","article-title":"Methylation of IGF2 regulatory regions to diagnose adrenocortical carcinomas","volume":"23","author":"Creemers","year":"2016","journal-title":"Endocr Relat Canc"},{"key":"10.1016\/j.humpath.2020.10.001_bib47","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s12022-018-9525-8","article-title":"Immunohistochemical biomarkers of adrenal cortical neoplasms","volume":"29","author":"Mete","year":"2018","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.humpath.2020.10.001_bib48","doi-asserted-by":"crossref","first-page":"8276","DOI":"10.1158\/0008-5472.CAN-10-2014","article-title":"Transcriptome analysis reveals that p53 and {beta}-catenin alterations occur in a group of aggressive adrenocortical cancers","volume":"70","author":"Ragazzon","year":"2010","journal-title":"Canc Res"},{"key":"10.1016\/j.humpath.2020.10.001_bib49","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/PAS.0000000000000341","article-title":"Mitotic count by phosphohistone H3 immunohistochemical staining predicts survival and improves interobserver reproducibility in well-differentiated neuroendocrine tumors of the pancreas","volume":"39","author":"Voss","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2020.10.001_bib50","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1210\/jc.2016-1460","article-title":"Familial adrenocortical carcinoma in association with lynch syndrome","volume":"101","author":"Challis","year":"2016","journal-title":"J Clin Endocrinol Metabol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817720301994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817720301994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:38:41Z","timestamp":1758645521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817720301994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":50,"alternative-id":["S0046817720301994"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2020.10.001","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Data set for reporting of carcinoma of the adrenal cortex: explanations and recommendations of the guidelines from the International Collaboration on Cancer Reporting","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2020.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}